CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)
Status:
Completed
Trial end date:
2018-06-20
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the efficacy, safety, and tolerability of CyclASol
Ophthalmic Solution in comparison to vehicle for the treatment of the signs and symptoms of
DED.